Download presentation
Presentation is loading. Please wait.
Published bySukarno Cahyadi Modified over 5 years ago
1
Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma John J. Condemi, MDa, Paul Chervinsky, MDb, Marc F. Goldstein, MDc, Linda B. Ford, MDd, William E. Berger, MDe, Garrison H. Ayars, MDf, Paula R. Rogenes, PhDg, Lisa Edwards, PhDg, Pamela J. Pepsin, RN, BAg Journal of Allergy and Clinical Immunology Volume 100, Issue 4, Pages (October 1997) DOI: /S (97) Copyright © 1997 Mosby, Inc. Terms and Conditions
2
Fig. 1 Mean change from baseline in morning predose FEV1 at end point (*p < 0.05 vs placebo, †p < 0.05 FP vs TAA). BID, Twice daily; QID; four times daily. End-point analysis = final estimable measurement for all patients including those who failed to complete the entire study. Journal of Allergy and Clinical Immunology , DOI: ( /S (97) ) Copyright © 1997 Mosby, Inc. Terms and Conditions
3
Fig. 2 Mean change from baseline in morning predose PEF (*p < 0.05 vs placebo, †p < 0.05 FP vs TAA). BID, Twice daily; QID, four times daily. End-point analysis = final estimable measurement for all patients including those who failed to complete the entire study. Journal of Allergy and Clinical Immunology , DOI: ( /S (97) ) Copyright © 1997 Mosby, Inc. Terms and Conditions
4
Fig. 3 Probability of remaining in the study according to Kaplan-Meier Survival Curve (p < vs placebo; p = 0.06, FP vs TAA). BID, Twice daily; QID, four times daily. Journal of Allergy and Clinical Immunology , DOI: ( /S (97) ) Copyright © 1997 Mosby, Inc. Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.